Cardiovascular Associates of America - CVAUSA · 5 months ago
Cardiologist (Interventional) - Citrus Cardiology Consultants
Cardiovascular Associates of America - CVAUSA is seeking a Full-Time Interventional Cardiologist to join their team at Citrus Cardiology Consultants in Central Florida. The role involves providing advanced cardiac care, including interventional procedures, within a collaborative environment while contributing to the growth of the practice.
Health CareHospital
Responsibilities
Join a Premier Cardiovascular Team in Central Florida – Citrus Cardiology Consultants
Work in our Leesburg/Tavares clinics and affiliated hospitals
Primarily Interventional services within our local clinics and hospital, which will include a mixture of coronary, both bread and butter and complex cases and clinical care
Some Non-Invasive services as well (i.e., echo, nuclear, etc)
Plans to add a new PET CT machine in 2026
State-of-the-art equipment and facilities across multiple clinic and hospital locations
Monday–Friday schedule with shared STEMI call support
Dedicated APP, MA, and administrative support in both clinic and hospital settings
Qualification
Required
Board Certified in Cardiovascular Medicine
Board Eligible or Board Certified in Interventional Cardiology
Completion of a U.S.-accredited Internal Medicine and Cardiovascular training program
MD or DO (new graduates and experienced physicians welcome)
Committed to patient-centered care, teamwork, and quality improvement
Can support J1 and H-1B physician waivers through the Southeast Crescent Regional Commission (SCRC)
Benefits
Strong base salary with additional bonus incentives
Partnership track with equity ownership potential
Sign-on bonus offering
Full benefits package including malpractice coverage, CME support, and retirement plan
Company
Cardiovascular Associates of America - CVAUSA
Headquartered in Orlando, Cardiovascular Associates of America aims to bring the best cardiovascular physicians in one network with the common mission of saving lives, reducing costs, and improving patient care through clinical innovation.
Funding
Current Stage
Growth StageTotal Funding
unknown2024-01-01Private Equity
Recent News
2025-07-30
Company data provided by crunchbase